These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 19888522)
1. The potential for circular dichroism as an additional facile and sensitive method of monitoring low-molecular-weight heparins and heparinoids. Rudd TR; Skidmore MA; Guimond SE; Holman J; Turnbull JE; Lauder RM; Fernig DG; Yates EA Thromb Haemost; 2009 Nov; 102(5):874-8. PubMed ID: 19888522 [TBL] [Abstract][Full Text] [Related]
2. Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides. Ludwig RJ; Schindewolf M; Alban S; Kaufmann R; Lindhoff-Last E; Boehncke WH Thromb Haemost; 2005 Dec; 94(6):1265-9. PubMed ID: 16411404 [TBL] [Abstract][Full Text] [Related]
8. Glycosaminoglycan origin and structure revealed by multivariate analysis of NMR and CD spectra. Rudd TR; Skidmore MA; Guimond SE; Cosentino C; Torri G; Fernig DG; Lauder RM; Guerrini M; Yates EA Glycobiology; 2009 Jan; 19(1):52-67. PubMed ID: 18832453 [TBL] [Abstract][Full Text] [Related]
9. Interaction of heparinoids with platelets: comparison with heparin and low molecular weight heparins. Messmore HL; Griffin B; Koza M; Seghatchian J; Fareed J; Coyne E Semin Thromb Hemost; 1991; 17 Suppl 1():57-9. PubMed ID: 1712512 [TBL] [Abstract][Full Text] [Related]
10. Allergy to heparins and anticoagulants with a similar pharmacological profile: an update. Jappe U Blood Coagul Fibrinolysis; 2006 Nov; 17(8):605-13. PubMed ID: 17102645 [TBL] [Abstract][Full Text] [Related]
11. Fondaparinux: a suitable alternative in cases of delayed-type allergy to heparins and semisynthetic heparinoids? A study of 7 cases. Jappe U; Juschka U; Kuner N; Hausen BM; Krohn K Contact Dermatitis; 2004 Aug; 51(2):67-72. PubMed ID: 15373846 [TBL] [Abstract][Full Text] [Related]
12. Variability of heparins and heterogeneity of low molecular weight heparins. Bianchini P; Liverani L; Spelta F; Mascellani G; Parma B Semin Thromb Hemost; 2007 Jul; 33(5):496-502. PubMed ID: 17629846 [TBL] [Abstract][Full Text] [Related]
14. Production and chemical processing of low molecular weight heparins. Linhardt RJ; Gunay NS Semin Thromb Hemost; 1999; 25 Suppl 3():5-16. PubMed ID: 10549711 [TBL] [Abstract][Full Text] [Related]
15. Properties of Heparinoids Premixed with Tumor-Derived Extracellular Vesicles. Manandhar S; Park J; Kothandan VK; Lee J; Alam F; Jee JP; Hwang J; Byun Y; Hwang SR Bioconjug Chem; 2018 Nov; 29(11):3757-3767. PubMed ID: 30372043 [TBL] [Abstract][Full Text] [Related]
16. Ultra-low-molecular-weight heparins: precise structural features impacting specific anticoagulant activities. Lima MA; Viskov C; Herman F; Gray AL; de Farias EH; Cavalheiro RP; Sassaki GL; Hoppensteadt D; Fareed J; Nader HB Thromb Haemost; 2013 Mar; 109(3):471-8. PubMed ID: 23329070 [TBL] [Abstract][Full Text] [Related]
17. Heparin and low molecular weight heparins as scaffolds for assembling antithrombin and serine proteases. Ofosu FA Thromb Res; 2008; 123(1):5-7. PubMed ID: 18284938 [No Abstract] [Full Text] [Related]
18. Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight. Commentary. Gómez-Outes A; Gómez de la Bárcena C; Martínez-González J Br J Dermatol; 2008 Apr; 158(4):869-70. PubMed ID: 18284394 [No Abstract] [Full Text] [Related]
19. Characterization of anticoagulant heparinoids by immunoprofiling. Wijnhoven TJ; van de Westerlo EM; Smits NC; Lensen JF; Rops AL; van der Vlag J; Berden JH; van den Heuvel LP; van Kuppevelt TH Glycoconj J; 2008 Feb; 25(2):177-85. PubMed ID: 17909966 [TBL] [Abstract][Full Text] [Related]